Clinical review: Irradiation for lower extremity arterial occlusive disease

Cardiovascular Radiation Medicine

Volumn 1, Issue 3, 1999, Pages 288-296

  Illig, Karl A ^a   Soni, Arvind ^a   Williams, Jacky ^a   Shortell, Cynthia K ^a   Green, Richard M ^a  

^a UNIVERSITY OF ROCHESTER MEDICAL CENTER   (United States)

Author keywords

Femoropopliteal bypass; Intimal hyperplasia; Prosthetic graft; Radiation therapy; Restenosis

Indexed keywords

ANASTOMOSIS; ARTERIOSCLEROSIS; BLOOD VESSEL PROSTHESIS; BLOOD VESSEL TRANSPLANTATION; HUMAN; HYPERPLASIA; LEG; METHODOLOGY; PATHOLOGY; PERIPHERAL OCCLUSIVE ARTERY DISEASE; REVIEW; STENOSIS, OCCLUSION AND OBSTRUCTION;

ANASTOMOSIS, SURGICAL; ARTERIAL OCCLUSIVE DISEASES; ARTERIOSCLEROSIS; BLOOD VESSEL PROSTHESIS; BLOOD VESSEL PROSTHESIS IMPLANTATION; CONSTRICTION, PATHOLOGIC; HUMANS; HYPERPLASIA; LEG;

EID: 0033157234     PISSN: 15221865     EISSN: None     Source Type: Journal    
DOI: 10.1016/S1522-1865(99)00017-7     Document Type: Article

References (52)

1. Vogt M.T., Wolfson S.K., Kuller L.H. Lower extremity arterial disease and the aging process. a review J. Clin. Epidemiol. 45:1992;529-542.
2. Newman A.B., Siscovick D.S., Manolio T.A.et al. Ankle-arm index as a marker of atherosclerosis in the cardiovascular health study. Circulation. 88:1993;837-845.
3. Fowkes F.G.R., Housley E., Cawood E.H.H.et al. Edinburgh artery study. prevalence of asymptomatic arterial disease in the general population Int. J. Epidemiol. 20:1991;384-392.
4. Stanley J.C., Barnes R.W., Ernst C.R.et al. Vascular surgery in the United States. workforce issues J. Vasc. Surg. 23:1996;172-181.
5. Illig K.A., Ouriel K. Nonoperative treatment of claudication. Cameron J.L. Current surgical therapy. 6th ed:1998;767-770 Mosby, St. Louis.
6. Money S.R., Herd J.A., Isaacsohn J.L.et al. Effect of cilostazol on walking distances in patients with intermittant claudication caused by peripheral vascular disease. J. Vasc. Surg. 27:1998;267-275.
7. Becquemin J.P., Cavillon A., Haiduc F. Surgical transluminal femoropopliteal angioplasty. multivariate analysis outcome J. Vasc. Surg. 19:1994;495-502.
8. Wilson S.E., Wolf S.L., Cross A.P. Percutaneous transluminal angioplasty versus operation for peripheral atherosclerosis. report of a prospective randomized trial in a selected group of patients J. Vasc. Surg. 9:1989;1-9.
9. Johnston K.W., Rae M., Hogg-Johnston S.A.et al. Five-year results of a prospective study of percutaneous transluminal angioplasty. Ann. Surg. 206:1987;403-413.
10. Golledge J., Ferguson K., Ellis M.et al. Outcome of femoropopliteal angioplasty. Ann. Surg. 229:1999;146-153.
11. Whyman M.R., Ruckley C.V. Should claudicants receive angioplasty or just exercise training? Cardiovasc. Surg. 6:1998;226-231.
12. Matsi P.J., Manninen H.I. Complications of lower-limb percutaneous angioplasty. a prospective analysis of 410 procedures on 295 consecutive patients Cardiovasc. Intervent. Radiol. 21:1998;361-366.
13. Martin D.R., Katz S.G., Kohl R.D.et al. Percutaneous transluminal angioplasty of infrainguinal vessels. Ann. Vasc. Surg. 13:1999;184-187.
14. Parsons R.E., Suggs W.D., Lee J.J.et al. Percutaneous transluminal angioplasty for the treatment of limb-threatening ischemia. do the results justify an attempt before bypass grafting? J. Vasc. Surg. 28:1998;1066-1071.
15. Taylor L.M., Edwards J.M., Porter J.M. Present status of reversed vein bypass grafting. five-year results of a modern series J. Vasc. Surg. 11:1990;193-206.
16. Leather R.P., Shah D.M., Corson J.D.et al. Instrumental evolution of the valve incision method of in situ saphenous vein bypass. J. Vasc. Surg. 1:1984;113-123.
17. Veith F.J., Gupta S.K., Ascer E.et al. Six-year prospective multicenter randomized comparison of autologous saphenous vein and expanded polytetrafluoroethylene grafts in infrainguinal revascularization. J. Vasc. Surg. 3:1986;104-114.
18. Sayers R.D., Raptis S., Berse M.et al. Long-term results of femorotibial bypass with vein or polytetrafluoroethylene. Br. J. Surg. 85:1998;934-938.
19. Green RM, Abbott WM, Matsumoto T, et al. Prosthetic above-knee femoropopliteal bypass: five-year results of a randomized trial. J. Vasc. Surg. (In press).
20. Dalman R.L., Taylor L.M. Infrainguinal revascularization procedures. Porter J.M., Taylor L.M. Basic data underlying clinical decision making in vascular surgery. 1994;141-143 Quality Medical Publishing, St. Louis.
21. Whittemore A.D. Infrainguinal bypass. Rutherford R.B. Vascular surgery. 4th ed:1995;794-814 WB Saunders, Philadelphia.
22. Archie J.P. Femoropopliteal bypass with either adequate ipsilateral reversed saphenous vein or obligatory polytetrafluoroethylene. Ann. Vasc. Surg. 8:1994;475-484.
23. Brewster D.C., LaSalle A.J., Robison J.G.et al. Femoropopliteal graft failures. clinical consequences and success of secondary revascularization Arch. Surg. 118:1983;1043-1050.
24. Szilagyi D.E., Elliott J.P., Hageman J.H.et al. Biologic fate of autogenous vein implants as arterial substitutes. clinical, angiographic, and histopathiologic observations in femoro-popliteal operations for atherosclerosis Ann. Surg. 178:1973;232-246.
25. Caps M.T., Cantwell-Gab K., Bergelin R.O.et al. Vein graft lesions. time of onset and rate of progression J. Vasc. Surg. 22:1995;466-475.
26. Davies M.G., Hagen P.O. Pathophysiology of vein graft failure. a review Eur. J. Vasc. Endovasc. Surg. 9:1995;7-18.
27. Ouriel K., Shortell C.K., DeWeese J.A.et al. A comparison of thrombolytic therapy with operative revascularization in the initial treatment of acute peripheral arterial ischemia. J. Vasc. Surg. 19:1994;1021-1030.
28. Ouriel K., Veith F.J., Sasahara A.A.et al. A comparison of recombinant urokinase with vascular surgery as initial treatment for acute arterial occlusion of the legs. N. Engl. J. Med. 338:1998;1105-1111.
29. Hunik M.G.M., Cullen K.A., Donaldson M.C. Hospital costs of revascularization procedures for femoropopliteal arterial disease. J. Vasc. Surg. 19:1994;632-641.
30. Allaire E., Clowes A.W. Endothelial cell injury in cardiovascular surgery. the intimal hyperplastic response Ann. Thorac. Surg. 63:1997;582-591.
31. Purcell C., McGeachie J., Tennant M. Neo-intimal hyperplasia in vascular grafts and its implications for autologous arterial grafting. Ann. R. Coll. Surg. Engl. 79:1997;164-168.
32. Chervu A., Moore W.S. An overview of intimal hyperplasia. Surg. Gynecol. Oncol. 171:1990;433-437.
33. Fortunato J.E., Glagov S., Bassiouny H.S. Irradiation for the treatment of intimal hyperplasia. Ann. Vasc. Surg. 12:1998;495-503.
34. Summer D.S. Essental hemodynamic principles. Rutherford R. Vascular surgery. 4th ed:1995;18-44 WB Saunders, Philadelphia.
35. Clowes A.W. Pathologic intimal hyperplasia as a response to vascular injury and reconstruction. Rutherford R. Vascular surgery. 4th ed:1995;285-295 WB Saunders, Philadelphia.
36. Lei M., Archie J.P., Kleinstreuer C. Computational design of a bypass graft that minimizes wall shear stress gradients in the region of the distal anastomosis. J. Vasc. Surg. 25:1997;637-646.
37. Nicolaides A.N. Haemodynamic and rheologic aspects of vascular grafts. Acta Chir. Scand. 538:1987;12-17.
38. Hofer M., Rappitsch G., Perktold K.et al. Numerical study of wall mechanics and fluid dynamics in end-to-side anastomoses and correlation to intimal hyperplasia. J. Biomech. 29:1996;1297-1308.
39. Trubel W., Schima H., Moritz A.et al. Compliance mismatch and formation of distal anastomotic intimal hyperplasia in externally stiffened and lumen-adapted venous grafts. Eur. J. Vasc. Endovasc. Surg. 10:1995;415-423.
40. Wiedermann J.G., Leavy J.A., Amols H.et al. Effects of high-dose intracoronary irradiation on vasomotor function and smooth muscle histopathology. Am. J. Physiol. 267:1994;H125-H132.
41. Wiedermann JG, Marboe C, Amols H, et al. Intracoronary irradiation markedly reduces neointial proliferation after balloon angioplasty in swine: persistent benefit at 6-month follow-up. J. Am. Coll. Cardiol. 1995:25:1451-1456.
42. Waksman R., Robinson K.A., Crocker I.R.et al. Endovascular low-dose irradiation inhibits neointima formation after coronary artery balloon injury in swine. Circulation. 91:1995;1533-1539.
43. Waksman R., Robinson K.A., Crocker I.R.et al. Intracoronary low-dose beta-irradiation inhibits neointima formation in swine after coronary artery balloon injury in the swine restenosis model. Circulation. 92:1995;3025-3031.
44. Tallman M.P., Williams J.P., Eagleton M.J.et al. The tolerance of normal rabbit femoral arteries to single high dose external beam irradiation. Cariovasc. Radiat. Med. 1:1999;131-137.
45. Shimotakahara S., Mayberg M.R. Gamma irradiation inhibits neointimal hyperplasia in rats after arterial injury. Stroke. 25:1994;424-428.
46. Verin V., Popowski Y., Urban P.et al. Intra-arterial irradiation prevents neointimal hyperplasia in a hypercholesterolemic rabbit restenosis model. Circulation. 92:1995;2284-2290.
47. Sarac T.P., Riggs P.N., Williams J.P.et al. The effects of low-dose radiation on intimal hyperplasia. J. Vasc. Surg. 22:1995;17-24.
48. Wiedermann J.G., Marboe C., Amols H.et al. Intracoronary irradiation markedly reduces restenosis after balloon angioplasty in a porcine model. J. Am. Coll. Cardiol. 23:1994;1491-1498.
49. Waksman R., Robinson K.A., Crocker I.R.et al. Intracoronary radiation before stent implantation inhibits neointima formation in stented porcine coronary arteries. Circulation. 92:1995;1383-1386.
50. Massullo V., Teirsein P.S., Jani S.et al. Endovascular brachytherapy to inhibit coronary artery restenosis. an introduction to the Scripps coronary radiation to inhibit proliferation post stenting trial Int. J. Radiat. Oncol. Biol. Phys. 36:1996;973-975.
51. Teirstein P.S., Massullo V., Jani S.et al. Catheter-based radiotherapy to inhibit restenosis after coronary stenting. N. Engl. J. Med. 336:1997;1697-1703.
52. Teirstein P.S., Massullo V., Jani S.et al. Two-year follow-up after catheter-based radiotherapy to inhibit coronary restenosis. Circulation. 99:1999;243-247.